Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer

Na Zhao1,2,3, Jin Cao1,2,3, Longyong Xu1,2,3

  • 1Department of Molecular and Cellular Biology.

Insights

Oncogenic MYC drives breast cancer by activating the unfolded protein response (UPR) via the IRE1/XBP1 pathway. Inhibiting this pathway selectively kills MYC-driven cancer cells and enhances chemotherapy.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Homeostasis

Background:

  • The unfolded protein response (UPR) is crucial in cancer, influencing tumor progression and treatment resistance.
  • Mechanisms of UPR activation and regulation in cancer remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which oncogenic MYC regulates the IRE1/XBP1 branch of the UPR in breast cancer.
  • To investigate the therapeutic potential of targeting the IRE1/XBP1 pathway in MYC-driven cancers.

Main Methods:

  • Investigated MYC's regulation of IRE1 transcription via promoter and enhancer binding.
  • Analyzed MYC-XBP1 transcriptional complex formation and activity.
  • Assessed the synthetic lethality of XBP1 silencing in MYC-hyperactivated cells.
  • Evaluated the efficacy of IRE1 RNase inhibitor 8866 in preclinical cancer models and in combination with docetaxel.

Main Results:

  • MYC directly controls IRE1 transcription and enhances XBP1 transcriptional activity.
  • XBP1 acts as a synthetic lethal partner to MYC; its silencing selectively inhibits MYC-hyperactivated cell growth.
  • Pharmacological inhibition of IRE1 RNase activity with 8866 suppressed MYC-overexpressing tumor growth in vivo.
  • 8866 significantly potentiated docetaxel efficacy, leading to rapid tumor regression.

Conclusions:

  • Established a synthetic lethal interaction between the IRE1/XBP1 pathway and MYC hyperactivation.
  • Demonstrated that targeting the IRE1/XBP1 pathway is a promising therapeutic strategy for MYC-driven breast cancers.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
9.9K
Combinatorial Gene Control02:33

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
9.7K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.9K
C4 Pathway and CAM01:27

C4 Pathway and CAM

Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
49.3K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
8.3K